Operator Good day, and welcome to the InMode fourth quarter and full year 2024 earnings results conference call. [Operator ...

Breast augmentation surgery is expensive with a long recovery time - but now, there's an alternative that's non-surgical and ...

Q4 2024 Results Conference Call February 4, 2025 8:30 AM ETCompany ParticipantsMiri Segal - CEO, MS-IRMoshe Mizrahy - ...

a randomized phase Ib-II MORPHEUS-Liver study showed. At the clinical cutoff date, the 41 patients assigned to treatment with tiragolumab had a confirmed objective response rate of 43% compared ...

Morpheus is committed to ensuring that builders are also recognized for their hard work, not just agents or compute providers The platform employs a distribution ...

The best Resident Evil games have been terrifying the generations for over 25 years. Since 1996, The Umbrella Corporation has dominated how we think about zombies and sinister pharmaceutical ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Jeffrey Hatrix, the former frontman for the popular metal band Mushroomhead, has given an update on his cancer battle just weeks after first making the revelation. In a post recently shared by his ...

ONCE upon a time, “work” meant a boring 9 to 5. Today, in my world, it means Botox, filler, polynucleotides, Profhilo, ...